Nature’s Sunshine Products (NASDAQ:NATR) Issues Earnings Results

Nature’s Sunshine Products (NASDAQ:NATR) posted its earnings results on Thursday. The company reported $0.21 EPS for the quarter, missing analysts’ consensus estimates of $0.27 by ($0.06), FiscalAI reports. Nature’s Sunshine Products had a net margin of 3.68% and a return on equity of 12.97%. The business had revenue of $116.99 million for the quarter, compared to analysts’ expectations of $123.70 million.

Here are the key takeaways from Nature’s Sunshine Products’ conference call:

• Second-quarter sales reached a company record of $117 million, rising 4% year over year in constant currency. Growth was broad-based, led by Asia-Pacific, North American digital sales, and Europe.
• North American digital sales increased 26%, with new customers up 26% and autoship representing 36% of website orders. Management highlighted that autoship customers have more than three times the lifetime value of other customers, while social-commerce revenue rose 177%.
• Gross margin expanded nearly 200 basis points to 73.7%, supported by logistics renegotiations, manufacturing efficiencies, sourcing improvements, and pricing discipline. The company expects margins to remain in the low- to mid-73% range for the rest of 2026.
• Management lowered 2026 guidance because of foreign-exchange changes and a slowdown in China, reducing its sales outlook to $490 million-$500 million from $500 million-$515 million and adjusted EBITDA guidance to $48 million-$52 million from $50 million-$54 million. China sales fell 20% in the quarter, although executives characterized the operational issues as short term.
• The company is beginning investments in its “Vision for Growth,” targeting $1 billion in sales and a 15% EBITDA margin over the long term through digital expansion, geographic growth, product innovation, and selective acquisitions. Planned initiatives include a North American direct-selling overhaul in early 2027, further international expansion, and potential supplement acquisitions that can use the company’s manufacturing capacity.

Nature’s Sunshine Products Price Performance

Shares of NATR stock opened at $16.38 on Friday. The stock’s fifty day moving average price is $20.62 and its 200 day moving average price is $23.50. Nature’s Sunshine Products has a 1-year low of $12.97 and a 1-year high of $28.14. The company has a market cap of $288.04 million, a price-to-earnings ratio of 16.22 and a beta of 0.88.

Insiders Place Their Bets

In other Nature’s Sunshine Products news, EVP Daniel C. Norman sold 9,713 shares of the stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $20.64, for a total value of $200,476.32. Following the completion of the sale, the executive vice president directly owned 47,276 shares in the company, valued at approximately $975,776.64. This trade represents a 17.04% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Bryant J. Yates sold 11,968 shares of the business’s stock in a transaction dated Friday, June 5th. The stock was sold at an average price of $19.90, for a total value of $238,163.20. Following the sale, the executive vice president owned 77,446 shares in the company, valued at $1,541,175.40. The trade was a 13.38% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 35,696 shares of company stock valued at $742,407. 3.10% of the stock is owned by corporate insiders.

Institutional Trading of Nature’s Sunshine Products

Several large investors have recently bought and sold shares of NATR. Boston Partners purchased a new position in shares of Nature’s Sunshine Products in the fourth quarter worth $4,544,000. Manatuck Hill Partners LLC acquired a new stake in shares of Nature’s Sunshine Products during the second quarter worth $1,923,000. Vanguard Group Inc. grew its holdings in shares of Nature’s Sunshine Products by 15.3% during the third quarter. Vanguard Group Inc. now owns 803,104 shares of the company’s stock valued at $12,464,000 after buying an additional 106,688 shares during the last quarter. Kennedy Capital Management LLC grew its holdings in shares of Nature’s Sunshine Products by 14.6% during the third quarter. Kennedy Capital Management LLC now owns 675,764 shares of the company’s stock valued at $10,488,000 after buying an additional 86,128 shares during the last quarter. Finally, Two Sigma Investments LP increased its position in shares of Nature’s Sunshine Products by 215.5% in the 3rd quarter. Two Sigma Investments LP now owns 119,798 shares of the company’s stock valued at $1,859,000 after acquiring an additional 81,830 shares during the period. Hedge funds and other institutional investors own 79.40% of the company’s stock.

Trending Headlines about Nature’s Sunshine Products

Here are the key news stories impacting Nature’s Sunshine Products this week:

• Neutral Sentiment: Nature’s Sunshine appointed Ruth Perkins as executive vice president and chief financial officer, effective September 1, 2026. She will oversee the company’s global finance organization, including financial planning, accounting, treasury, tax, investor relations, and financial reporting. Nature’s Sunshine Appoints Ruth Perkins as Executive Vice President and Chief Financial Officer
• Neutral Sentiment: Management discussed the second-quarter performance and business outlook during its earnings call, providing additional context for the results and updated guidance. Nature’s Sunshine Products Q2 2026 Earnings Call Transcript
• Negative Sentiment: Second-quarter adjusted earnings were $0.21 per share, below the $0.27 analyst consensus, while revenue of $116.99 million trailed expectations of $123.70 million. The earnings and sales shortfalls raised concerns about near-term profitability and demand. Nature’s Sunshine Reports Second Quarter 2026 Results
• Negative Sentiment: The company lowered its full-year 2026 revenue outlook to $490 million–$500 million, below the analyst consensus of approximately $506.4 million. The reduced forecast likely reinforced investor concerns about slower growth. Nature’s Sunshine misses Q2 2026 sales expectations

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the stock. DA Davidson upgraded shares of Nature’s Sunshine Products to a “strong-buy” rating in a research note on Monday, July 6th. Weiss Ratings downgraded shares of Nature’s Sunshine Products from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 9th. Wall Street Zen lowered Nature’s Sunshine Products from a “strong-buy” rating to a “buy” rating in a report on Saturday. Finally, Canaccord Genuity Group dropped their target price on Nature’s Sunshine Products from $37.00 to $36.00 and set a “buy” rating on the stock in a research report on Thursday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $34.50.

Nature’s Sunshine Products Company Profile

Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.

The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.